Abilify sNDA For Major Depressive Disorder Gets Priority Review

 
• By Jessica Merrill

Bristol/Otsuka are seeking a broader indication for the atypical antipsychotic for MDD as adjunctive to antidepressant therapy.

More from Archive

More from Pink Sheet